Authors: Schlesinger, Z Vered, Z Friedenson, A Reisin, L Jafari, J Flieb, T Sclarovsky, S Friedman, Y Ostfeld, B Solodky, A Abinader, E Rochfleish, S Palant, A Schneider, H Rosenfeld, T Khalid, S Wolfson, E Kishon, Y Narinsky, R Rotzak, R Davidov, A Levine, G Zahavi, I Vitrai, J Diker, D Pelled, B Pardu, J Galamidi, J Majadla, R Laniado, S Sherf, L Braun, S Eschar, Y Caspi, A Arditi, A Botwin, S Arkavi, L Ziv, M David, D Weisenberg, D Kohanovski, M Meisel, S Rougin, N Yahalom, M Glusman-Vazan, A Markiewitz, W Motlak, D Lessick, J Kagan, G Marmour, A Flich, M Solomon, R Tzivoni, D Zion, M Balkin, J Rabinowitz, B Barasch, E Brill, Z Aharon, L Asman, A Battler, A Gueron, M Cristal, N Liel, N Tsatskis, B Henkin, J

Citation: Z. Schlesinger et al., Secondary prevention by raising HDL cholesterol and reducing triglyceridesin patients with coronary artery disease - The bezafibrate infarction prevention (BIP) study, CIRCULATION, 102(1), 2000, pp. 21-27